Your browser doesn't support javascript.
loading
PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy.
Shu, Fei; Punekar, Salman R; Velcheti, Vamsidhar; Sanmamed, Miguel F; Wang, Jun.
Affiliation
  • Shu F; Department of Pathology, New York University Grossman School of Medicine, NYU Langone Health, New York, New York.
  • Punekar SR; The Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Velcheti V; The Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Sanmamed MF; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Wang J; Department of Pathology, New York University Grossman School of Medicine, NYU Langone Health, New York, New York.
Clin Cancer Res ; 28(15): 3182-3184, 2022 08 02.
Article in En | MEDLINE | ID: mdl-35648093

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Neoplasms Limits: Humans Language: En Journal: Clin Cancer Res Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Neoplasms Limits: Humans Language: En Journal: Clin Cancer Res Year: 2022 Document type: Article